Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.
Journal: The New England journal of medicine
Published: July 29, 2026
Implementation Journey with CAB LA for PrEP Among Men Who Have Sex with Men and Transgender Men: Insights from the PILLAR Trial Through 12 Months.
Journal: AIDS and behavior
Published: June 16, 2026
HIV rebound in HIV controllers is associated with a specific fecal microbiome profile.
Journal: European journal of immunology
Published: February 27, 2024
The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy.
Journal: Science translational medicine
Published: December 23, 2020
Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.
Journal: Sexual health
Published: April 24, 2018
Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial.
Journal: Current HIV research
Published: June 24, 2016
HIV: THE BASICS.
Journal: Positively aware : the monthly journal of the Test Positive Aware Network
Published: December 31, 2015
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: April 14, 2015
Management of dyslipidemia in patients with human immunodeficiency virus.
Journal: Reviews in cardiovascular medicine
Published: July 03, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026